Evidence map›Paper›PMID 30550871›Full record

ArticleNeoplasia (New York, N.Y.)2019

Stromal PTEN Regulates Extracellular Matrix Organization in the Mammary Gland.

Caitlin E Jones, Anisha M Hammer, YouJin Cho, Gina M Sizemore, Edna Cukierman, Lisa D Yee, Samir N Ghadiali, Michael C Ostrowski, Jennifer L Leight

Open access · goldAbstract read
In one paragraph

Article in Neoplasia (New York, N.Y.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.1field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 50 citations in OpenAlex.

  1. Review
  2. Loss of phosphatase and tensin homolog (Cancer pathogenesis and therapy · 2025
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Caitlin E JonesDepartment of Biomedical Engineering, College of Engineering, The Ohio State University, Columbus, OH 43210.
Anisha M HammerDepartment of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH 43210.
YouJin ChoDepartment of Biomedical Engineering, College of Engineering, The Ohio State University, Columbus, OH 43210.
Gina M SizemoreDepartment of Radiation Oncology, College of Medicine, The Ohio State University, Columbus, OH 43210; The James Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210.
Edna CukiermanDepartment of Cancer Biology, Fox Chase Cancer Center, Temple Health, Philadelphia, PA 19111.
Lisa D YeeThe James Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210; Department of Surgery, The Ohio State University, Columbus, OH 43210.
Samir N GhadialiDepartment of Biomedical Engineering, College of Engineering, The Ohio State University, Columbus, OH 43210; Dorothy M. Davis Heart and Lung Research Institute, College of Medicine and Wexner Medical Center, The Ohio State University, Columbus, OH 43210; Department of Internal Medicine (Division of Pulmonary, Critical Care and Sleep Medicine), College of Medicine and Wexner Medical Center, The Ohio State University, Columbus, OH 43210.
Michael C OstrowskiThe James Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210; Department of Cancer Biology and Genetics, The Ohio State University, Columbus, OH 43210.
Jennifer L LeightDepartment of Biomedical Engineering, College of Engineering, The Ohio State University, Columbus, OH 43210; The James Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210. Electronic address: leight.1@osu.edu.
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute · USThe Ohio State University · USFox Chase Cancer Center · USThe Ohio State University Wexner Medical Center · US

Funding

WORD PROCESSING CENTER--COREP30CA006927 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI Margaret von Mehren · 1985 to 2026
$138.8M
Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Tasleem J Padamsee · 1985 to 2026
$132.3M
3D-Adhesion Stromagenesis in Cancer PermissivenessR01CA113451 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI CUKIERMAN, EDNA · 2006 to 2016
$2.8M
PDGFR beta signaling in the tumor microenvironment of metastatic breast cancerK22CA218472 · NCI · OHIO STATE UNIVERSITY · PI SIZEMORE, GINA MARIE · 2017 to 2019
$561k
NCI NIH HHS K22 CA218472NCI NIH HHS P30 CA006927NCI NIH HHS P30 CA016058NCI NIH HHS R01 CA113451
6 · The paper itself

Abstract

The organization of the extracellular matrix has a profound impact on cancer development and progression. The matrix becomes aligned throughout tumor progression, providing "highways" for tumor cell invasion. Aligned matrix is associated with breast density and is a negative prognostic factor in several cancers; however, the underlying mechanisms regulating this reorganization remain poorly understood. Deletion of the tumor suppressor Pten in the stroma was previously shown to promote extracellular matrix expansion and tumor progression. However, it was unknown if PTEN also regulated matrix organization. To address this question, a murine model with fibroblast-specific Pten deletion was used to examine how PTEN regulates matrix remodeling. Using second harmonic generation microscopy, Pten deletion was found to promote collagen alignment parallel to the mammary duct in the normal gland and further remodeling perpendicular to the tumor edge in tumor-bearing mice. Increased alignment was observed with Pten deletion in vitro using fibroblast-derived matrices. PTEN loss was associated with fibroblast activation and increased cellular contractility, as determined by traction force microscopy. Inhibition of contractility abrogated the increased matrix alignment observed with PTEN loss. Murine mammary adenocarcinoma cells cultured on aligned matrices derived from Pten

Indexed as

AnimalsBreast DensityCell Line, TumorCell MovementCollagenExtracellular MatrixFemaleFibroblastsGene Knockout TechniquesHumansMammary Glands, AnimalMammary Glands, HumanMiceMice, TransgenicPTEN PhosphohydrolaseStromal CellsCollagenPTEN Phosphohydrolase

Identifiers

PMID30550871
PMCPMC6293034
OpenAlexW2904619904

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.